ir para o conteúdo principal
Logo Default

Unidade Local de Saúde (ULS) - Guarda

Unidade Local de Saúde (ULS) - Guarda

Institution Description

Unidade Local de Saúde da Guarda (ULSG) is a corporate entity governed by public law. It was created on the 10th of January of 2008, through the Legislative Decree No. 183/2008, of the 4th of September. It brings together two hospitals (Guarda and Seia) and the thirteen Health Centers of the former Guarda Health Sub region (Almeida, Celorico da Beira, Figueira de Castelo Rodrigo, Fornos de Algodres, Gouveia, Guarda, Manteigas, Meda, Pinhel, Sabugal, Seia, Trancoso and the Vila Nova de Foz Côa Health Center, which became part of the ULSG since 05/01/2014, through the Legislative Decree No. 5/2014, of April 16th). Thus, in the District of Guarda, only the municipality of Aguiar da Beira is not included in the ULSG.
Its mission is the integrated facility of primary, hospital, palliative and convalescent care to the population in its area of influence, with active mobilization of the surrounding community, increasing the levels of health and well-being, ensuring the activities of operative public health services and the means necessary to exercise the powers of the health authority, as well as research, training and teaching activities.
Its vision is based on population recognition as well as employees and other entities as an organization that ensures a high-quality response to the health needs of its users throughout the life cycle, guided by strict principles of efficiency and responsibility in the economic, financial, social and environmental fields.

ULSG has as its main reference in the citizen, conciliation of health strategies (regional and national) and the optimization of available resources.

Based on the intention to pursue a guiding culture of personalized and excellent care, its objectives are:

  • Promote the achievement of health gains, providing continuous and effective services with added value;
  • Ensure the provision of excellent health care to all users;
  • Prevent disease and promote health through greater focus on prevention, early diagnosis and treatment and patient education;
  • Achieve full integration of care in organizational, clinical, administrative, financial, normative and systemic dimensions;
  • Promote a holistic view of care provision, shared and recognized by employees, partners and users;
  • Ensure easy access for patients to adequate and timely healthcare;
  • Ensure the adjustment of health care to the needs of the population;
  • Provide professionals with continuous training, adequate to improve care performance and professional progress and accomplishment;
  • Enhance an internal culture focused on the acquisition of transversal skills and teamwork;
  • Develop teaching and scientific research.

In this context, the Clinical Trials Office (GEC) was created to reinforce the incentive to the growth of research and innovation, furthering the promotion of scientific and technological knowledge.

Thus, the innovation process that begins in the laboratory, identifying new molecules and promising future treatments has a long way to go before reaching clinical practice.

Also in this line of action, the ULSG signed a collaboration protocol with Blue Clinical for the promotion of Clinical Research.

Year

Download
General Indicators
No. of active clinical studies by study type
  • 7
    Active Clinical Trials
  • 2
    Active Non-Interventional Studies
No. of initiated clinical studies by study type
  • 2
    Clinical Trials initiated
  • 0
    Non-Interventional Studies initiated
No. of active non-interventional clinical studies by therapeutic area
No. of active non-interventional clinical studies by sponsor type
No. of active Clinical trials by sponsor type
No. of active clinical trials per phase
No. of active clinical trials by trial object
No. of active clinical trials by therapeutic area
  • 40
    No. of publications in indexed journals - last 5 full years
  • 60
    No. of health professionals with specific training in GCP (Good Clinical Practices)
Global Capacity Indicators
  • 328
    No. of available beds in the institution
  • 210
    No. of Physicians in the Institution
  • 817
    No. of Nurses in the Institution
  • 13
    No. of Pharmacists in the Institution
  • 137 767 thousand
    No. of Inhabitants covered by the institution
HR Indicators Allocated to Research
Total number of people dedicated to clinical research in the institution
  • 20
    Researchers
  • 3
    Managers, Administrative, Legal and Financial
  • 1
    Study coordinators
  • 10
    Nurses
  • 4
    Pharmacists
Efficiency Indicators
  • 11
    Total number of participants recruited for clinical trials and interventional clinical studies of medical devices
  • 0%
    Patient recruitment rate in clinical trials and interventional clinical studies of medical devices
  • 60 days
    Average time to first patient recruitment in clinical trials and interventional clinical studies of medical devices
  • 15 days
    Average time between submission and approval of the Financial Contract in clinical trials and interventional clinical studies of medical devices
General Indicators
No. of active clinical studies by study type
  • 5
    Active Clinical Trials
  • 1
    Active Non-Interventional Studies
No. of initiated clinical studies by study type
  • 5
    Clinical Trials initiated
  • 1
    Non-Interventional Studies initiated
No. of active non-interventional clinical studies by therapeutic area
No. of active non-interventional clinical studies by sponsor type
No. of active Clinical trials by sponsor type
No. of active clinical trials per phase
No. of active clinical trials by trial object
No. of active clinical trials by therapeutic area
  • 23
    No. of publications in indexed journals - last 5 full years
  • 37
    No. of health professionals with specific training in GCP (Good Clinical Practices)
Global Capacity Indicators
  • 350
    No. of available beds in the institution
  • 223
    No. of Physicians in the Institution
  • 801
    No. of Nurses in the Institution
  • 11
    No. of Pharmacists in the Institution
  • 138 211 thousand
    No. of Inhabitants covered by the institution
HR Indicators Allocated to Research
Total number of people dedicated to clinical research in the institution
  • 24
    Researchers
  • 5
    Managers, Administrative, Legal and Financial
  • 1
    Study coordinators
  • 9
    Nurses
  • 3
    Pharmacists
Efficiency Indicators
  • 1
    Total number of participants recruited for clinical trials and interventional clinical studies of medical devices
  • 0%
    Patient recruitment rate in clinical trials and interventional clinical studies of medical devices
  • 60 days
    Average time to first patient recruitment in clinical trials and interventional clinical studies of medical devices
  • 50 days
    Average time between submission and approval of the Financial Contract in clinical trials and interventional clinical studies of medical devices
General Indicators
No. of active clinical studies by study type
  • 14
    Active Clinical Trials
  • 7
    Active Non-Interventional Studies
No. of initiated clinical studies by study type
  • 5
    Clinical Trials initiated
  • 1
    Non-Interventional Studies initiated
No. of active non-interventional clinical studies by therapeutic area
No. of active non-interventional clinical studies by sponsor type
No. of active Clinical trials by sponsor type
No. of active clinical trials per phase
No. of active clinical trials by trial object
No. of active clinical trials by therapeutic area
  • 11
    No. of publications in indexed journals - last 5 full years
  • 73
    No. of health professionals with specific training in GCP (Good Clinical Practices)
Global Capacity Indicators
  • 309
    No. of available beds in the institution
  • 212
    No. of Physicians in the Institution
  • 816
    No. of Nurses in the Institution
  • 16
    No. of Pharmacists in the Institution
  • 137 743 thousand
    No. of Inhabitants covered by the institution
HR Indicators Allocated to Research
Total number of people dedicated to clinical research in the institution
  • 8
    Researchers
  • 4
    Managers, Administrative, Legal and Financial
  • 2
    Study coordinators
  • 9
    Nurses
  • 4
    Pharmacists
Efficiency Indicators
  • 35
    Total number of participants recruited for clinical trials and interventional clinical studies without medical devices
  • 90%
    Patient recruitment rate in clinical trials and interventional clinical studies without medical devices
  • 15 days
    Average time to first patient recruitment in clinical trials and interventional clinical studies of medical devices
  • 15 days
    Average time between submission and approval of the Financial Contract in clinical trials and interventional clinical studies of medical devices

Clinical Research Areas of interest

Clinical Research Areas of interest

  • Oncologia;
  • Cardiologia (Doença Coronária e Insuficiência Cardíaca);
  • Neurologia;
  • Gastrenterologia;
  • Hipertensão e Risco Cardiovascular;
  • Doenças Lisossomais de Sobrecarga;
  • Pneumologia.

Latest News